chr2-47005909-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020458.4(TTC7A):​c.1066-13G>A variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 1,613,518 control chromosomes in the GnomAD database, including 15,110 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2728 hom., cov: 32)
Exomes 𝑓: 0.13 ( 12382 hom. )

Consequence

TTC7A
NM_020458.4 splice_polypyrimidine_tract, intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.281
Variant links:
Genes affected
TTC7A (HGNC:19750): (tetratricopeptide repeat domain 7A) This gene encodes a protein containing tetratricopeptide repeats. Mutations in this gene disrupt intestinal development and can cause early onset inflammatory bowel disease and intestinal atresia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-47005909-G-A is Benign according to our data. Variant chr2-47005909-G-A is described in ClinVar as [Benign]. Clinvar id is 403573.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.28 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TTC7ANM_020458.4 linkuse as main transcriptc.1066-13G>A splice_polypyrimidine_tract_variant, intron_variant ENST00000319190.11 NP_065191.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TTC7AENST00000319190.11 linkuse as main transcriptc.1066-13G>A splice_polypyrimidine_tract_variant, intron_variant 2 NM_020458.4 ENSP00000316699 P1Q9ULT0-1

Frequencies

GnomAD3 genomes
AF:
0.170
AC:
25823
AN:
151974
Hom.:
2721
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.284
Gnomad AMI
AF:
0.0154
Gnomad AMR
AF:
0.162
Gnomad ASJ
AF:
0.152
Gnomad EAS
AF:
0.000577
Gnomad SAS
AF:
0.0976
Gnomad FIN
AF:
0.129
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.130
Gnomad OTH
AF:
0.171
GnomAD3 exomes
AF:
0.130
AC:
32638
AN:
250978
Hom.:
2533
AF XY:
0.128
AC XY:
17303
AN XY:
135632
show subpopulations
Gnomad AFR exome
AF:
0.287
Gnomad AMR exome
AF:
0.132
Gnomad ASJ exome
AF:
0.145
Gnomad EAS exome
AF:
0.000924
Gnomad SAS exome
AF:
0.100
Gnomad FIN exome
AF:
0.131
Gnomad NFE exome
AF:
0.134
Gnomad OTH exome
AF:
0.136
GnomAD4 exome
AF:
0.125
AC:
183011
AN:
1461426
Hom.:
12382
Cov.:
32
AF XY:
0.125
AC XY:
90583
AN XY:
727004
show subpopulations
Gnomad4 AFR exome
AF:
0.299
Gnomad4 AMR exome
AF:
0.136
Gnomad4 ASJ exome
AF:
0.145
Gnomad4 EAS exome
AF:
0.000680
Gnomad4 SAS exome
AF:
0.101
Gnomad4 FIN exome
AF:
0.131
Gnomad4 NFE exome
AF:
0.125
Gnomad4 OTH exome
AF:
0.132
GnomAD4 genome
AF:
0.170
AC:
25863
AN:
152092
Hom.:
2728
Cov.:
32
AF XY:
0.168
AC XY:
12482
AN XY:
74364
show subpopulations
Gnomad4 AFR
AF:
0.285
Gnomad4 AMR
AF:
0.162
Gnomad4 ASJ
AF:
0.152
Gnomad4 EAS
AF:
0.000578
Gnomad4 SAS
AF:
0.0975
Gnomad4 FIN
AF:
0.129
Gnomad4 NFE
AF:
0.130
Gnomad4 OTH
AF:
0.169
Alfa
AF:
0.138
Hom.:
1611
Bravo
AF:
0.177
Asia WGS
AF:
0.0630
AC:
219
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJan 24, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 27% of patients studied by a panel of primary immunodeficiencies. Number of patients: 26. Only high quality variants are reported. -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxJul 09, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Multiple gastrointestinal atresias Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
9.4
DANN
Benign
0.77

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs13407983; hg19: chr2-47233048; API